Published • loading... • Updated
AAN 2026: BlueRock Reports Positive Safety Data for Bemdaneprocel in Parkinson’s
Summary by Clinical Trials Arena
2 Articles
2 Articles
AAN 2026: BlueRock reports positive safety data for bemdaneprocel in Parkinson’s
Bemdaneprocel is a cell therapy composed of human embryonic stem cell-derived midbrain dopaminergic neuron progenitor cellsThe post AAN 2026: BlueRock reports positive safety data for bemdaneprocel in Parkinson’s appeared first on Clinical Trials Arena.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium